Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Haematologica
|
August 19, 2017
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
Staci D Arnold, Ruta Brazauskas, Naya He, et al.
Cancer
|
October 21, 2020
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Sanghee Hong, Ruta Brazauskas, Kyle M Hebert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Zachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
Robert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Blood
|
July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Lori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Blood Advances
|
September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Leukemia Research
|
July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Haematologica
|
August 19, 2017
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
Staci D Arnold, Ruta Brazauskas, Naya He, et al.
Cancer
|
October 21, 2020
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Sanghee Hong, Ruta Brazauskas, Kyle M Hebert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Zachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
Robert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Blood
|
July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Lori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Blood Advances
|
September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Leukemia Research
|
July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.
Page
of 5